Viewing StudyNCT00460798



Ignite Creation Date: 2024-05-05 @ 5:28 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00460798
Status: COMPLETED
Last Update Posted: 2010-11-16
First Post: 2007-04-13

Brief Title: SUTENT In The First Line Treatment Of Renal Cell Carcinoma
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Renal Cell Carcinoma
Keywords:
Name View
kidney cancer View
Sunitinib View
kidney diseases View
urogenital neoplasms View